Drug Approval | February 17, 2024
Lupin receives approval from USFDA for Minzoya
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
The product is expected to be launched in June 2023
Testing supporting allergy diagnosis now accessible to more people in more communities
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Subscribe To Our Newsletter & Stay Updated
